Fair Value Calculator Fair Value Calculator
EN DE

0954 (0954) Fair Value & Analysis

Basic Materials · Market cap HK$154M

0 0954 0954 · HK
PriceHK$0.2900
Fair ValueHK$0.2700
Upside-6.9%
Quality51/100
Evidence: Medium Range HK$0.2000 – HK$0.3400

Fair value as of: Jul 2, 2026

From 10 valuation models · updated today

Share price −9.4% over the past month.

Price vs Fair Value (12 months)

HK$0.3600 HK$0.2750 Fair Value HK$0.2700 Jun 2025 Jun 2026

12‑month range HK$0.2750 – HK$0.3600 · fair‑value band HK$0.2000 – HK$0.3400 · the HK$0.2900 price screens above the HK$0.2700 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0954 (0954) currently trades at HK$0.2900, while our model-based Fair Value estimate is HK$0.2700 — implying the stock looks roughly 6.9% overvalued today. We read business quality at 51/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0954 generated revenue of HK$557M at a net margin of -12.0%. Revenue grew 5.0% year over year. It earns a return on equity of -12.2%. Net debt stands at HK$471M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$557M
Revenue growth (YoY) +5.0%
Net margin -12.0%
Return on equity -12.2%
Free cash flow HK$9.9M FY2025
Operating margin -6.1%
More key figures
EPS (TTM) HK$-0.0500
EPS growth (YoY) -89.8%
Net debt HK$471M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0954 reported revenue of HK$557M in FY2025 versus HK$548M in FY2021, a compound +0.4%/yr. Reported net income was −HK$66.8M in FY2025.

Revenue +0.4%/yr
FY21 HK$548M
FY22 HK$730M
FY23 HK$637M
FY24 HK$585M
FY25 HK$557M
Net income
FY21 HK$58.3M
FY22 HK$81.4M
FY23 −HK$86.1M
FY24 −HK$68.2M
FY25 −HK$66.8M

Is 0954 fairly valued? → Check now

Similar stocks

6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $507.90 $142.21 -72%
L'Air Liquide S.A AIQUY $37.93 $15.46 -59%
Air Products and Chemicals, Inc A1PD34 R$360.05 R$174.71 -51%
Intercontinental Exchange, Inc I1CE34 R$367.00 R$311.38 -15%
Wanhua Chemical Group 600309 ¥67.90 ¥46.52 -31%
Asian Paints Limited ASIANPAINT ₹2,687 ₹655.71 -76%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0954 (0954) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.2700 versus a price of HK$0.2900 — about −7% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 0954?
Our model-based fair value for 0954 is HK$0.2700 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2900.
What is the quality score of 0954?
0954 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0954 (0954)?
0954 reported trailing-twelve-month revenue of about HK$557M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 0954?
The net profit margin of 0954 is about -12.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.